OrbiMed Capital GP VII LLC, 10% Owner at Passage BIO, Inc. (PASG), sold 97,103 shares at $0.79 ($77K) on 2024-12-04, disclosed to the SEC on 2024-12-06.
Open-market sale of $77k PASG by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.79 | 76,200 | $60K | 77.8% |
| 2 | $0.82 | 20,903 | $17K | 22.2% |
| Total | $0.80 avg | 97,103 | $77K | 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |
| ELVN | SELL | 2024-05-20 | $22.9M | — | Filing → |